-
Risk Factors for Neonatal White-Centered Retinal Hemorrhages: Clinical Implications for Prevention
27 Mar 2025 13:21 GMT
… aspiration syndrome, congenital heart disease, neonatal hyperbilirubinemia, and maternal … congenital heart disease. In Group 4, significant factors included … other hemostatic factors in neonates, including elevated von Willebrand factor, hematocrit, …
-
Hemab Therapeutics Presents Interim Data from Ongoing Phase 2 Study of HMB-001 as First Ever Prophylactic Treatment in Glanzmann Thrombasthenia and Preclinical Data from HMB-002 in Von Willebrand Disease at the 2025 EAHAD Annual Congress
07 Feb 2025 14:13 GMT
… the disease, a condition driven by a deficiency or defect in Von Willebrand Factor (VWF … -clotting disorders like Glanzmann thrombasthenia, Factor VII Deficiency, Von Willebrand Disease, and others. Learn more …
-
Risk Assessment and Prevention of Venous Thromboembolism in Critically Ill Patients in Tibet: A Prospective Cohort Study with Historical Controls
03 Apr 2025 11:16 GMT
… particularly high due to various factors, including prolonged immobilization, invasive … local epidemiology and risk factors to guide appropriate preventive … production and increased expression of von Willebrand factor (vWF), promoting platelet adhesion …
-
von Willebrand disease: Star Therapeutics, Chugai and Band Therapeutics are breaking new ground
09 Jan 2025 14:55 GMT
… for von Willebrand disease has lagged.”
So what’s currently available for von Willebrand disease patients … and stabilizes factor VIII, another essential clotting protein.
“In von Willebrand disease, patients have …
-
Star Therapeutics’ von Willebrand disease therapy gains FDA fast track status
07 Jan 2025 12:12 GMT
… (FDA) for the treatment of von Willebrand disease (VWD).
The ‘fully human’, immunoglobulin … the cofactor function for tissue factor pathway inhibitor α (TFPIα) and activated … drug innovation for this debilitating disease that has lagged behind other …
-
Star Therapeutics Receives FDA Fast Track Designation for VGA039 in Von Willebrand Disease (VWD)
06 Jan 2025 13:08 GMT
… Track designation for VGA039 in von Willebrand disease (VWD). VGA039 is an … drug innovation for this debilitating disease that has lagged behind other … disorders, with the first disease indication of von Willebrand disease (VWD). As a subcutaneously …
-
The Benefits of Sustaining High Factor VIII Levels in People With Hemophilia A
04 Mar 2025 03:23 GMT
… risk for atherosclerosis and cardiovascular disease. In PwHA who require … independence of efanesoctocog alfa from von Willebrand factor may reduce interpatient pharmacokinetic … Holstein K, Martinoli C. Joint disease in haemophilia: pathophysiology, pain and …
-
Star Therapeutics Presents Interim Clinical Data for VGA039 in Patients with Von Willebrand Disease (VWD) at ASH 2024
09 Dec 2024 18:26 GMT
…
3980: Diagnosis and Disease Burden of Von Willebrand Disease in a Large US … with Von Willebrand Disease in a Large US Population-Based Dataset
3982: Factor … in VWD patients (NCT05776069).
About von Willebrand disease
Von Willebrand disease (VWD) is the most …
-
Coagulation Market Size Set to Reach USD 10.85 Billion by 2030, Driven by Rising Blood Disorder Cases and Advancements in Treatment Technologies - The Insight Partners
01 Apr 2025 14:41 GMT
… most prevalent inherited clotting factor deficiency after von Willebrand disease. According to the … hemophilia, 87,729 cases of von Willebrand disease, and 64,394 cases … blood disorders such as hemophilia, von Willebrand disease, deep vein thrombosis, and …
-
Novel Biomarkers as Non-Invasive Diagnostic Tools in IgA Nephropathy: A Comparative Study with Lupus Nephritis and Membranous Nephropathy
02 Apr 2025 07:51 GMT
… variations. The medication profiles revealed disease-specific treatment patterns: glucocorticoids were … -deficient immunoglobulin A1; vWF, von Willebrand Factor; VEGF, vascular endothelial growth factor; sFlt-1, soluble …